期刊文献+

哈萨克族人群中FVLeiden突变的研究 被引量:2

Study of Factor V Leiden Mutation in Kazak Nationality
下载PDF
导出
摘要 目的 研究分析中国新疆哈萨克族健康人群中FVLeiden突变的发生率。方法 应用多聚酶链反应 限制性片段长度多态性分析 (PCR RFLP) ,对新疆地区 183例 (汉族 98例 ;哈萨克族 85例 )健康个体进行FVLeiden基因突变研究分析。结果 哈萨克族人群中检出 3例FVLeiden(FVArg50 6→Gln)突变杂合子 ;汉族人群中均无该突变类型。结论 中国新疆地区哈萨克族人群中存在FVLeiden基因突变 ,而汉族人群中未检测到该类型突变 ,FVLeiden突变可能不是中国人群静脉血栓 (VT)发病的主要危险因素。不同种族人群的VT致病的分子机制存在差异。 Objective To study the prevalence of factor V Leiden mutation in healthy Kazak nationality in Xinjiang district. Methods By using the polymerase chain reaction (PCR) and restriction enzyme analysis, 183 normal individuals (Han, n=98; Kazak, n=85) were studied. Result 3 cases of heterozygous for FV Leiden mutation (FV Arg 506 →Gln) were detected in Kazak individuals, while no this mutation in Han subjects. Conclusion FV Leiden mutation is present in Chinese, but might not be a main risk factor in pathogenesis of VT in Chinese. There may be the plausible pathogenic divergence in VT among different races.
出处 《临床军医杂志》 CAS 2001年第2期5-8,共4页 Clinical Journal of Medical Officers
关键词 凝血因子V 基因突变 静脉血栓 杂合子 抗活化蛋白C现象 FV Leiden gene mutation venous thrombosis heterozygote activated proteinc C resistance
  • 相关文献

参考文献13

  • 1VOORBEG J, ROELSE J, KOOPMAN R, et al. Association of idiopathicthr-omboembolism with single point-mutation at Arg506 of factor V[J]. Lancet, 1994, 343:1535.
  • 2DAHLBACK B, CARLSSON M, SVENSSON PJ, et al. Familial thrombophilia due to apreviously unrecognized mechanism characterized by poor anticoagulant response toactivated protein c: prediction of a cofactorto activated protein c[J]. Proc Natl Sci USA,1993, 90: 1004.
  • 3KOELEMAN BPC, REITSMA PH, ALLAART CF, et al. Activated protein C resistance as anadditional risk factor for thrombosis in protein cdefi-cient families[J]. Blood, 1994, 84:1031.
  • 4PONCZ M, SOLOWIEJCZYK D, HARPEL B, et al. Construction of human gene libraries fromsmall amounts of peripheral Blood: Analysis of β-like globin genes[J]. Hemoglobin, 1982,6(1): 27.
  • 5BERTINA RM, KOELEMAN BPC, KOSTER T, et al. Mutation in blood coagulation factor Vassociated with resistance to activated protein c[J]. Nature, 1994, 369: 64.
  • 6COOPER DN. The molecular genetics of familiar renous thrombosis[J]. Blood-Rev,1991, 5(1): 55.
  • 7DAHLBACK B. INHERITED. Thrombophilia: resistance to activated protein c as apathogenic factor of venous thromboembolism[J]. Blood, 1995, 85: 607.
  • 8SVENSSON PJ, DAHLBACK B. Resitance to activated protein c as a basis for venousthrombosis[J]. N Engl J Med, 1994, 330: 517.
  • 9吴竞生,顾建明,JHMorrissey,孙自敏,汪健,NEsmon.一例FⅤ Leiden基因突变所致的抗活化的蛋白C现象[J].中华血液学杂志,1997,18(9):453-456. 被引量:28
  • 10储海燕,诸江,王鸿利,邵慧珍,张庆华,张宇舟,王学锋,杨景文,陈竺,王振义.上海地区深静脉血栓形成患者抗活化的蛋白C及FⅤLeiden突变的初步调查[J].中华血液学杂志,1996,17(9):462-465. 被引量:34

二级参考文献3

  • 1Sun X,Blood,1994年,83卷,3120页
  • 2储海燕,中华血液学杂志,1996年,17卷,462页
  • 3罗佳滨,中华医学遗传学杂志,1996年,13卷,219页

共引文献52

同被引文献48

  • 1罗佳滨,关月,马洪星,李少英,李月秋,吕学诜.凝血因子V基因点突变1691 A在不同种族人群中的分布[J].中华医学遗传学杂志,1996,13(4):219-220. 被引量:17
  • 2贾玮,吴琦,李月川.肺血栓栓塞症患者抗凝系统变化的研究[J].天津中医药大学学报,2006,25(2):77-79. 被引量:2
  • 3Zivelin A, Griffin JH, Xiao Xu, et al. A single genetic origin for a common caucasian risk factor for venous thrombosis [ J ]. Blood, 1997,89 (2) : 397-402.
  • 4Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium [J]. N Engl J Med, 2000, 342(6) : 374-380.
  • 5Lindqvist PG, Svensson PJ, Marsal K, et ah Activated protein C resistance (FV : Q506) and pregnancy [ J ]. Thromb Haemost, 1999,81 (4) : 532-537.
  • 6Ridker PM, Hermekens CH, Lindpaintner K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men [J]. N Engl J Med, 1995,332(14):912.
  • 7Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously imrecognized mechanism characterized by poor anticoagulant response to activated protein C [J]. Proc Natl Acad Sci USA, 1993,90(3): 1004-1008.
  • 8Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with activated protein C [J]. Nature, 1994,369(6475) :64-67.
  • 9Rosendaal FR, Koster T, Vandenbroucke JP, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) [J]. Blood, 1995,85(6): 1504-1508.
  • 10Zivelin A, Griffin JH, Xiao Xu, et al. A single genetic origin for a common caucasian risk factor for venous thrombosis [ J ]. Blood, 1997,89 (2) : 397-402.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部